| Features: |
This kit includes pathogen Free BME which has been tested and cleared of a Battery of 31 pathogens and viruses including LDEV. Contact Trevigen for details. |
| |
| Applications: |
Quantitative in vivo angiogenesis analysis, for the screening of inhibitors. |
| |
| Components: |
Part # |
Component |
Size |
| |
3450-048-01 |
Angioreactors |
48 units |
| |
3450-048-02 |
Growth Factor Reduced BME PathClear |
6 x 200 µl |
| |
3450-048-03 |
Wash Buffer |
25 ml |
| |
3450-048-05 |
CellSperse™ |
15 ml |
| |
3450-048-06 |
200X FITC-Lectin |
250 µg/50 µl |
| |
3450-048-07 |
25X FITC-Lectin Diluent |
400 µl |
| |
3450-048-08 |
Heparin Solution |
10 µl |
| |
3450-048-B10 |
FGF-2(1800 ng)/VEGF(600 ng) |
60 µl |
| |
| |
*Basement Membrane Extract (BME) |
| |
| Storage: |
Components are stored at -20°C and 4°C. |
| |
| References: |
Guedez L, Rivera AM, Salloum R, Miller ML, Diegmueller JJ, Bungay PM, Stetler-Stevenson WG: Quantitative Assessment of Angiogenic Response by the Directed In Vivo Angiogenesis Assay. AJP 2003, pp 1431-1439. |
